Related Experiment Videos
Treatment with intravenous colchicine.
Cranio : the Journal of Craniomandibular Practice
|January 1, 1991
Summary
This study investigated colchicine treatment for resistant temporomandibular joint (TMJ) symptoms in 27 patients. Both intravenous and oral colchicine showed potential in managing TMJ disorders, despite known side effects.
Area of Science:
- Rheumatology
- Dentistry
- Pharmacology
Background:
- Temporomandibular joint (TMJ) disorders present complex symptomatology.
- Resistant TMJ symptoms pose challenges for conventional dental and medical treatments.
- Colchicine, an ancient medication, is recognized for its anti-inflammatory properties, particularly in treating gouty arthritis.
Purpose of the Study:
- To evaluate the efficacy of intravenous and oral colchicine in treating patients with resistant temporomandibular related symptomatology.
- To compare the outcomes of colchicine treatment based on dental and medical diagnoses.
Main Methods:
- A study involving 27 patients diagnosed with resistant temporomandibular related symptomatology.
- Treatment administered included both intravenous and oral formulations of colchicine.
- Patient outcomes were assessed based on both dental and medical diagnostic criteria post-treatment.
Main Results:
- Colchicine treatment, administered via intravenous and oral routes, was evaluated for its impact on resistant TMJ symptoms.
- The study compared patient diagnoses before and after colchicine therapy.
- Potential side effects, such as chemical burns at the injection site with intravenous administration, were noted.
Conclusions:
- Colchicine demonstrates potential as a treatment option for resistant temporomandibular disorders.
- Further research is warranted to fully understand the risk-benefit profile of colchicine in TMJ treatment.
- The study highlights the historical significance and modern application of colchicine in managing inflammatory conditions.